Skip to main content

Security report for bioclinica.com

Bioclinica · Pharmaceuticals · United states

Partial score · DNS & email only

58/100

0–100, higher is better. How it is calculated

Scanned

4 of 7 checks could not complete. The site may be unreachable or blocking automated scans, so the results below cover only what could be checked. Try a rescan later.

NIS2 and GDPR posture

GDPR outside view
85/ 100 · Low
Checks completed
3of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching bioclinica.com

This scan found 8 issues across 2 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

Security headers
30
GDPR outside view
85
Average
58

Not counted

  • SSL/TLS: did not complete in this scan.
  • Email security: did not complete in this scan.
  • DNS health: did not complete in this scan.
  • Network security: did not complete in this scan.
  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Clario operates a B2B business model focused on providing advanced clinical trial endpoint technologies and services. Their market position is strong, supported by acquisitions such as WCG’s eCOA portfolio and NeuroRx imaging provider, enhancing their service breadth. The company leverages a global operational infrastructure with trials in over 100 countries and supports regulatory approvals for numerous drugs. Their partnership ecosystem includes integrations with AWS and other technology providers. The company emphasizes patient-centric solutions and operational excellence, driving growth through innovation and scientific rigor.

Security posture

The website enforces HTTPS and employs domain status protections to prevent unauthorized changes, indicating a mature security posture. However, DNSSEC is not enabled, and some recommended security headers like Content-Security-Policy and X-Content-Type-Options are missing. No explicit incident response or vulnerability disclosure contacts are published, which could be improved. Cookie consent is managed via Cookiebot, supporting GDPR compliance. Overall, the security posture is good but could be enhanced by adopting additional DNS and HTTP security best practices.

Recommendations

  1. Enable DNSSEC on the domain to strengthen DNS security and prevent spoofing.
  2. Implement a Content-Security-Policy header to mitigate cross-site scripting and related attacks.
  3. Add X-Content-Type-Options header to prevent MIME sniffing vulnerabilities.
  4. Publish a security.txt file to provide clear vulnerability disclosure and incident response contacts.
  5. Enhance transparency by providing explicit security incident contact channels on the website.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Clario
Description
Clario generates the richest clinical evidence by fusing deep scientific expertise and global scale into the broadest endpoint technology platform for clinical trial management.
Key services
eCOA Clinical Trials, Artificial Intelligence solutions for clinical trials, Cardiac Solutions, Medical Imaging, Precision Motion, Respiratory Solutions, Trial Enablement, Decentralized Trials
Content quality
excellent
Branding
consistent

Technology

Stack
jQuery, HubSpot Forms, Google Tag Manager, YouTube iframe API, Visual Website Optimizer (VWO), Cookiebot, Lottie Player
Frameworks
WordPress, Understrap Bootstrap theme
Platforms
WordPress CMS
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
75/100
Good practices seen
  • HTTPS enforced
  • ClientDeleteProhibited domain status
  • ClientRenewProhibited domain status
  • ClientTransferProhibited domain status
  • ClientUpdateProhibited domain status
  • Cookie consent mechanism implemented

Analytics and tracking

Services
Google Tag Manager, Visual Website Optimizer (VWO)
Tracking level
moderate
Privacy practices
good

Advertising

Ad networks
Google Ads (AW-977449037)
Tracking pixels
Visual Website Optimizer (VWO)
Marketing tools
HubSpot Forms, Cookiebot
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is professionally designed and content-rich
  2. Strong focus on clinical trial endpoint technology and services
  3. Comprehensive navigation with detailed solutions and resources
  4. Multiple forms use HubSpot for lead capture and contact
  5. No exposed emails or phone numbers found; contact via forms
  6. Social media presence on Twitter and LinkedIn
  7. Cookie consent implemented via Cookiebot
  8. No explicit security.txt or incident response contacts found
  9. DNSSEC not enabled, which is a minor security gap
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with bioclinica.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review bioclinica.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.

bioclinica.com security report (partial scan) | Guard